Geri
NewcelX AG (NCEL) Kazanmak
NCEL Hisse Senedi Fiyat Grafiği
NCEL Kazanmak
NewcelX AG
$2.25
-4.04%
$-0.09
Kapanışta: Apr 02, 16:00:00 GMT-4
$2.27
0.66%
$0.01
Sonrası Piyasa: Apr 02, 20:00:00 GMT-4
Önemli İstatistikler
Önceki Kapanış
$2.35
Açılış fiyatı
$2.3
Günün Aralığı
$2.18 - $2.35
52 haftalık aralık
$1.83 - $30.8
İşlem hacmi
23.5K
Ort.Hacim
88.7K
Dividend yield
--
EPS (TTM)
-5.27
Piyasa Değeri
$10.3M
NCEL nedir?
NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The firm offers products like Quilience, which is a clinical-stage pharmaceutical compound. The company aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The firm also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The firm is a publicly traded company, listing on the NASDAQ.
Özellikler
Kaynaklar
© 2026 Finture Development Limited. Tüm hakları saklıdır.